Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis

Abroad (travel likely)RecruitingPHASE4

Conditions

Osteoporosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • National Taiwan University Hospital Yunlin Branch, Douliu, Taiwan, Taiwan

    Contact: Study coordinator (Shau-Huai Fu, PhD) · b90401045@gmail.com · 0972655734
    Study coordinator · b90401045@gmail.com
    Contact: Principal Investigator (Shau-Huai Fu, PhD)